Re-evaluation of categorial outcomes using common clinically relevant improvement thresholds following bilateral L2 medial branch restorative neurostimulation versus sham

Comparing bilateral L2 medial branch restorative neurostimulation to sham at the primary endpoint of 120 days, employing common clinically-relevant thresholds for treatment success, this sponsor-funded reanalysis of the sham-controlled pivotal trial demonstrated statistically-significant and clinically meaningful benefits in favor of treatment in disability, quality of life, and patient satisfaction, while changes in pain bore mixed results.